Side Effects of Versed (Midazolam) in Children
The most critical side effects of Versed (midazolam) in children are respiratory depression, apnea, and oxygen desaturation, which can lead to death or hypoxic encephalopathy if not promptly recognized and treated. 1
Life-Threatening Respiratory Complications
Respiratory depression is the primary serious adverse effect requiring immediate recognition and intervention 1, 2:
- Apnea and respiratory arrest can occur, particularly when combined with opioids or other CNS depressants
- Oxygen desaturation occurs in 4.6-15% of pediatric patients receiving IV midazolam 1
- Risk increases dramatically when midazolam is combined with fentanyl or other sedatives—the synergistic effect can increase respiratory depression risk substantially 3
- Neonates are at highest risk: rapid IV administration in neonates has caused severe hypotension and seizures, particularly with concomitant fentanyl use 1
Critical Monitoring Requirements
The FDA label explicitly mandates 1:
- Continuous monitoring of respiratory and cardiac function with pulse oximetry
- Immediate availability of resuscitative drugs and age-appropriate bag/valve/mask equipment
- Personnel trained in airway management must be present
- A dedicated individual (separate from the proceduralist) should monitor deeply sedated pediatric patients
Common Adverse Effects by Route
Intravenous Administration
The most frequent side effects include 1, 3:
- Oxygen desaturation: 4.6-13% of cases
- Apnea: 2.8%
- Hypotension: 2.7%
- Hiccoughs: 1.2%
- Seizure-like activity: 1.1%
- Nystagmus: 1.1%
Paradoxical Reactions
Paradoxical agitation occurs in 0.6-2.0% of pediatric patients, especially in younger children 2, 1:
- Manifests as inconsolable crying, combativeness, disorientation, agitation, restlessness, and tachycardia 4
- Occurs more frequently in children under 6 years of age 2
- Typically begins approximately 17 minutes after midazolam administration 4
- Can be reversed with flumazenil, with resolution within 14 minutes 4
Cardiovascular Effects
Less common but significant cardiovascular complications include 1:
- Hypotension (particularly in neonates with rapid administration)
- Bradycardia
- Tachycardia
- Premature ventricular contractions
- Vasovagal episodes
Neurological Effects
Additional CNS-related adverse effects 1:
- Prolonged emergence from sedation
- Confusion and disorientation
- Ataxia and dizziness
- Slurred speech
- Athetoid movements
- Emergence delirium or agitation
Gastrointestinal Effects
Minor but notable GI side effects 1:
- Nausea (2.8%)
- Vomiting (2.6%)
- Excessive salivation
- Acid taste
Age-Specific Considerations
Dosing and risk profiles vary significantly by age 1, 5:
- Neonates: Highest risk group; avoid rapid injection; increased risk of hypotension and seizures
- Children <6 years: Require higher mg/kg doses but have increased risk of paradoxical reactions
- Children 6-12 years: Generally require 0.025-0.05 mg/kg initially, up to 0.4 mg/kg total
- Younger children consistently require closer monitoring 1
Risk Mitigation Strategies
Based on guideline recommendations 2, 3:
- Titrate slowly: Administer IV doses over at least 2 minutes; wait 2+ minutes between doses to assess effect
- Use appropriate formulations: The 1 mg/mL formulation facilitates slower injection
- Avoid rapid injection in neonates at all costs
- When combining with opioids: Expect 10-20% of patients to experience mild respiratory events requiring oxygen or stimulation 3
- Have flumazenil immediately available for reversal of life-threatening respiratory depression (though this will also reverse anticonvulsant effects) 2
- Calculate doses based on ideal body weight in obese children 1
Duration of Monitoring
Observe patients for at least 60 minutes after the procedure 3, with particular attention to:
- Residual sedation effects that could cause airway obstruction in car safety seats
- Re-sedation after discharge (especially with longer-acting formulations)
- Complete recovery before discharge with a responsible adult
The evidence consistently demonstrates that while midazolam is effective for pediatric sedation, the margin between therapeutic effect and respiratory compromise is narrow, particularly when combined with other sedatives. Vigilant monitoring and immediate rescue capability are non-negotiable requirements for safe use.